To investigate this in a more physiologically relevant setting, we tested the responsiveness of monocytes and hMDM derived from patients with FMF (Fig 7D) to Pyrin inflammasome activators compared to healthy donors. The gene discussed is MEFV; the disease is familial Mediterranean fever.